These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 22037588)

  • 21. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
    Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
    PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic mitochondrial pathology in Alzheimer's disease.
    Du H; Guo L; Yan SS
    Antioxid Redox Signal; 2012 Jun; 16(12):1467-75. PubMed ID: 21942330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel MicroRNA-455-3p and its protective effects against abnormal APP processing and amyloid beta toxicity in Alzheimer's disease.
    Kumar S; Reddy AP; Yin X; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2428-2440. PubMed ID: 31181293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease.
    Reddy PH; Yin X; Manczak M; Kumar S; Pradeepkiran JA; Vijayan M; Reddy AP
    Hum Mol Genet; 2018 Jul; 27(14):2502-2516. PubMed ID: 29701781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early selective vulnerability of synapses and synaptic mitochondria in the hippocampal CA1 region of the Tg2576 mouse model of Alzheimer's disease.
    Balietti M; Giorgetti B; Casoli T; Solazzi M; Tamagnini F; Burattini C; Aicardi G; Fattoretti P
    J Alzheimers Dis; 2013; 34(4):887-96. PubMed ID: 23313923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
    Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
    Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.
    Reddy PH
    Exp Neurol; 2009 Aug; 218(2):286-92. PubMed ID: 19358844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. POTENTIAL APPROACHES FOR REDUCING AMYLOID β PRODUCTION.
    Zheng C; Lan Y; Zhang J; Zhang L; Wu J; Guo S
    Acta Pol Pharm; 2016 Jul; 73(4):835-842. PubMed ID: 29648708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
    Willén K; Sroka A; Takahashi RH; Gouras GK
    J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody.
    Mandler M; Rockenstein E; Ubhi K; Hansen L; Adame A; Michael S; Galasko D; Santic R; Mattner F; Masliah E
    J Alzheimers Dis; 2012; 28(4):783-94. PubMed ID: 22064070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.
    Reddy PH; Beal MF
    Trends Mol Med; 2008 Feb; 14(2):45-53. PubMed ID: 18218341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small molecules as therapeutic drugs for Alzheimer's disease.
    Oliver DMA; Reddy PH
    Mol Cell Neurosci; 2019 Apr; 96():47-62. PubMed ID: 30877034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer's disease.
    Pickett EK; Rose J; McCrory C; McKenzie CA; King D; Smith C; Gillingwater TH; Henstridge CM; Spires-Jones TL
    Acta Neuropathol; 2018 Nov; 136(5):747-757. PubMed ID: 30191401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer's disease.
    Reddy PH; Manczak M; Kandimalla R
    Hum Mol Genet; 2017 Apr; 26(8):1483-1496. PubMed ID: 28186562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
    Gouras GK; Willén K; Faideau M
    Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. OCIAD1 contributes to neurodegeneration in Alzheimer's disease by inducing mitochondria dysfunction, neuronal vulnerability and synaptic damages.
    Li X; Wang L; Cykowski M; He T; Liu T; Chakranarayan J; Rivera A; Zhao H; Powell S; Xia W; Wong STC
    EBioMedicine; 2020 Jan; 51():102569. PubMed ID: 31931285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.